Purchase Order 75N95022P00579
Award Date 9/27/22
Potential Completion Date 9/26/26
Potential Value $141K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Marshallton, DE 19808, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a firm-fixed-price purchase order to Agilent Technologies Inc. Customer Service And Sales Division for maintenance services on a government-owned Agilent CrossLab 7710CS cryogenic system. The $162,804.96 contract has a base year and four one-year option periods, for a total potential duration of five years. The National Center for the Advancement of Transalational Sciences (NCATS)...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a firm fixed-price purchase order to Agilent Technologies Inc. Customer Service And Sales Division for an automated liquid handling platform. The potential value of the contract is $150,380.10, and the period of performance ends on October 31, 2019. Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied chemical markets, providing laboratories...
- This federal contract award is for $149,639.77 and was issued by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to Agilent Technologies Inc., a global leader in life sciences, diagnostics, and applied chemical markets. The contract is for the purchase of scientific instruments, equipment, and services to support research at the agency. The contract does not have a set-aside designation and is a firm-fixed-price purchase order with a...
- The National Institute on Drug Abuse issued a purchase order to Agilent Technologies Inc. on June 16, 2021, valued at $82,746.94 for preventive maintenance and service on an Agilent Bravo liquid handler under a CrossLab Silver service agreement. Work is performed in Rockville, Maryland, with a period of performance from June 16, 2021, through June 15, 2022. The purchase order is firm fixed price with no set-aside designation. This order is being de-obligated to close unexpended and expiring...
- <p>The National Institute on Drug Abuse issued a purchase order to Agilent Technologies Inc. on March 2, 2022, for relocation of Agilent Bravo and Infinity HPLC equipment, with a ceiling value of $25,343.78. Work is performed in Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of April 30, 2022. The procurement originated from a pre-solicitation opportunity posted January 18, 2022.</p>
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Agilent Technologies Inc. Customer Service and Sales Division for $151,086.60. The contract is for preventative maintenance and on-call repair services for NIDA's Agilent MR-400 nuclear magnetic resonance (NMR) spectrometer over a 5-year period from September 24, 2019 to September 23, 2024. The contract includes one...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (NIDA) awarded a $128,606.64 firm fixed price purchase order to Agilent Technologies Inc. Customer Service And Sales Division to provide a multimodal microplate reader with a plate stacker, known as the Synergy Neo2 or equal. This equipment is required by NIDA's Molecular Mechanisms of Cellular Stress and Inflammation (MMCSI) program to efficiently analyze various cell-based assays and...
- The U.S. Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded a $150,013.62 delivery order contract to Agilent Technologies Inc. Customer Service And Sales Division, a subsidiary of Agilent Technologies, Inc. The contract is for the provision of scientific equipment and services under the General Services Administration's Scientific Equipment and Services (FSS-66) schedule. Agilent, a global leader in life sciences, diagnostics, and...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $214,955.48 firm fixed price purchase order to Agilent Technologies Inc. Customer Service And Sales Division, a subsidiary of the manufacturing company Agilent Technologies, Inc. The contract is for the delivery of a BIOTEK CYTATION C10 CONFOCAL IMAGER AND MULTIMODAL PLATE READER and will be performed in Bethesda, Maryland. Agilent Technologies is a global leader in life sciences,...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a delivery order contract to Agilent Technologies Inc. for the purchase of a 1260 Infinity II Multisampler, a high-performance liquid chromatography instrument that can handle well plates and individual sample containers. The $25,008.97 firm-fixed-price contract was placed against Agilent's General Services Administration Federal Supply Schedule 66 for Scientific Equipment and...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $140,515.20 firm-fixed-price purchase order contract to Agilent Technologies Inc. Customer Service And Sales Division for annual service and maintenance of Agilent cryobay equipment. The contract has a completion date of September 26, 2026, and was awarded on September 27, 2022. This contract is not associated with a larger contract vehicle. No set-aside was used for this procurement.
Generated 3/21/24, 10:19 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | $34.3k | 9/19/23 | |
| P00001 | Exercise an Option | $0 | 7/13/23 | |
| Not listed | Not listed | $34.3k | 9/1/22 |